.Pharmacolibrary.Drugs.V_Various.V09C_RenalSystem.V09CX02_SodiumIodohippurate131i.SodiumIodohippurate131i .Pharmacolibrary.Drugs.V_Various.V09C_RenalSystem.V09CX02_SodiumIodohippurate131i.SodiumIodohippurate131i| name: | SodiumIodohippurate131i | |
| ATC code: | V09CX02 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 10 | mg |
| volume of distribution: | 0.18 | L |
| clearance: | 622 | mL/min |
| other parameters in model implementation | ||
Sodium iodohippurate (131I), also known as radiohippuran, is a radiopharmaceutical agent labeled with iodine-131, historically used in nuclear medicine for renal imaging and assessment of renal plasma flow and function. It serves primarily as a diagnostic tool in renal scintigraphy. Its use has largely been replaced by agents with improved safety profiles and lower radiation exposure, such as Tc-99m-MAG3.
Representative pharmacokinetic model parameters reported in adult healthy volunteers following intravenous administration.